United States v. Bernard Greenspan

923 F.3d 138
CourtCourt of Appeals for the Third Circuit
DecidedApril 17, 2019
Docket17-2458
StatusPublished
Cited by39 cases

This text of 923 F.3d 138 (United States v. Bernard Greenspan) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Bernard Greenspan, 923 F.3d 138 (3d Cir. 2019).

Opinion

BIBAS, Circuit Judge.

Sometimes, the only plausible explanation for a lab's stream of payments to a doctor is cash for blood. Over seven years, Dr. Bernard Greenspan referred more than 100,000 blood tests to Biodiagnostic Laboratory Services. The Lab made more than $3 million off these tests. In exchange, the Lab gave Greenspan and his associates more than $200,000 in cash, gifts, and other benefits.

A jury convicted Greenspan of fraud and of taking bribes and kickbacks. He raises four claims of error. But none warrants reversal, particularly because the evidence of his guilt was overwhelming.

First, the District Court suggested at one point that Greenspan bore the burden of proof on his advice-of-counsel defense. And it improperly excluded and limited evidence on this defense. But the unpreserved jury-instruction error did not prejudice him. And the Court's errors in excluding and limiting related evidence were harmless.

Second, the Court properly excluded evidence that the blood tests were medically necessary. That evidence was only marginally relevant and risked misleading the jury.

Third, we need not decide whether the prosecution constructively amended the indictment to broaden the potential bases for conviction. Even if it did, Greenspan's trial counsel never objected to any amendment. And any error would not have seriously affected the proceedings' fairness, integrity, or public reputation because the evidence was overwhelming and essentially uncontroverted.

Fourth, the Court erred in asking only Greenspan's counsel, not Greenspan personally, whether he wished to speak at sentencing. As his counsel explained, Greenspan chose not to allocute and used other ways to plead for leniency. But this was a deliberate tactical choice, and we will not reward this litigation strategy. So we will affirm.

I. BACKGROUND

Greenspan was a long-time family doctor who ran a solo medical practice. The Lab tests blood samples so doctors, including Greenspan, can diagnose and treat their patients. For years, the Lab made a series of payments to Greenspan and his practice. Most of the Lab's payments are undisputed. The key dispute at trial was whether Greenspan took these payments as bribes or kickbacks in exchange for referring blood tests to the Lab. The prosecution's three cooperating witnesses insisted that Greenspan did, but Greenspan consistently denied it.

A. The alleged bribery and kickback scheme

Health-insurance companies negotiate low rates for blood tests with labs that are in their network. But they sometimes let out-of-network labs test blood samples and charge higher rates. That creates a lucrative business opportunity for out-of network labs if they can persuade doctors to send blood samples to them.

Brothers David and Scott Nicoll bought the Lab and ran it with their cousin, Craig Nordman. All three men eventually pleaded guilty to bribing roughly a hundred doctors for referrals, and testified against Greenspan as cooperating witnesses.

In early 2006, David visited Greenspan and persuaded him to start referring blood tests to the Lab. His visit came at an opportune time: Greenspan's medical practice was bleeding cash. As Greenspan's long-time office manager testified, sometimes Greenspan and his staff could not draw a salary. And the doctor complained to his staff weekly that he needed more money. Over the next seven years, Greenspan, his medical practice, his staff, his son, and even his mistress received a variety of benefits from the Lab, David and Scott Nicoll, Nordman, and Nordman's shell company, Advantech.

Everyone agreed that Greenspan tried to steer blood to the Lab. On cross-examination, Greenspan admitted that "yes, [he] would try. Yes, [he] would try" to "send the blood to [David's] laboratory" and that "David Nicoll knew [Greenspan] would try to send [David] blood." App. 2523; accord App. 2525. David testified that, right after Greenspan agreed to send blood to the Lab, Greenspan called in his office manager and told her that the office would "do whatever [it] could to help support [David]." App. 1083. The office manager corroborated that Greenspan told that to her: "If you can use [the Lab], use [the Lab]." App. 1614. Greenspan then began sending blood to the Lab.

The heart of the case at trial was whether Greenspan was steering blood tests to the Lab in exchange for payments and other benefits. Here are the payments and benefits:

1. Rent payments . Federal bribery, kickback, and fraud laws forbid any quid pro quo for blood-test referrals. But until 2010, New Jersey allowed blood labs to put a phlebotomist (a professional trained to draw blood) in a doctor's office in exchange for rental payments. So David offered Greenspan an on-site phlebotomist plus $2000 per month in rent to accommodate her.

Greenspan asked his lawyer, the late Barry Cohen, to review the contract. According to David, Greenspan asked Cohen: "How do we make this contract look legitimate and how do we get it to pass the smell test"? App. 1064. Cohen allegedly reviewed the contract in front of them and advised against using a round number. So the Lab lowered the rent from $2000 to $1992.50 per month and began paying that amount. Greenspan denied that David was present at the meeting and disputed David's account of what was said.

In the contract, the Lab promised to pay monthly rent in exchange for the phlebotomist's using 50% of Greenspan's 2000-square-foot office. But those numbers were dubious in several respects. Greenspan's office was only about 1658 square feet, not 2000. And even though the phlebotomist shared access to bathrooms, waiting areas, and other rooms, she occupied only one room that took up less than 5% of the office, not 50%.

Though the Lab used very little space, its rent payments began at more than 50% of the rent Greenspan paid for the entire office. And the Lab's rent increased over time. By 2010, the Lab paid more than 66% of Greenspan's rent.

And that is not all: Greenspan was also collecting $1750 per month in rent from two other companies that shared some of the rooms supposedly used by the phlebotomist. So Greenspan made a substantial profit from renting his office space.

2. Service fees . On top of its rent, the Lab paid Greenspan service fees for the costs associated with drawing blood. It did so even though it was also providing the phlebotomist and paying her salary to do just that. By 2010, these fees were $1748 per month.

3. Consulting fees . In July 2010, New Jersey banned labs from renting space from and entering into service agreements with doctors. N.J. Admin. Code § 8:44-2.14 (a)(2) (2010). So the Lab ended its rental agreement with Greenspan. Instead, it engaged him as a consultant.

David testified that he met with Greenspan in November 2010 to discuss an alternative payment plan. He said that he first offered Greenspan cash payments, but the doctor worried about depositing large amounts of cash each month. So they agreed to pay him consulting fees indirectly through a shell company called Advantech.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. James
2025 UT 53 (Utah Supreme Court, 2025)
BRENNER v. OVERMEYER
M.D. Pennsylvania, 2025
United States v. Novis (Denkberg)
139 F.4th 147 (Second Circuit, 2025)
United States v. Joseph Cammarata
129 F.4th 193 (Third Circuit, 2025)
United States v. Michael Hughes
117 F.4th 104 (Third Circuit, 2024)
United States v. Dion Oliver
Third Circuit, 2024
United States v. Davit Davitashvili
97 F.4th 104 (Third Circuit, 2024)
Elliott v. Piazza
M.D. Pennsylvania, 2023

Cite This Page — Counsel Stack

Bluebook (online)
923 F.3d 138, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-bernard-greenspan-ca3-2019.